US35655L2060 - ADR
FREELINE THERAPEUTICS HOLDIN
NASDAQ:FRLN (2/16/2024, 7:00:24 PM)
After market: 6.48 0 (0%)6.48
0 (0%)
Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. The company is headquartered in Stevenage, Hertfordshire and currently employs 152 full-time employees. The company went IPO on 2020-08-07. The firm is developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from chronic debilitating diseases. The company uses its rationally designed AAV vector and capsid (AAVS3), along with novel promoters and transgenes, to deliver a functional copy of a therapeutic gene into human liver cells, thereby expressing a persistent functional level of the missing or dysfunctional protein into a patient’s bloodstream. The company is advancing FLT201, a differentiated gene therapy candidate that delivers a novel transgene, in a Phase 1/2 clinical trial in people with Gaucher disease type 1. Therapeutic AAV vectors consist of two main components: the capsid and the expression cassette (that contains the gene and the promoter). The company has additional programs in research, including one focused on GBA1-linked Parkinson’s disease that leverages the same novel transgene as FLT201.
FREELINE THERAPEUTICS HOLDIN
Sycamore House, Gunnels Wood Road, Stevenage
Stevenage HERTFORDSHIRE SG1 2FX
P: 4401438906870
CEO: Theresa Heggie
Employees: 152
Website: https://www.freeline.life/
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting...
Acquisition of Freeline by Syncona Becomes Effective ...
Freeline Shareholders Approve Acquisition by Syncona...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Here you can normally see the latest stock twits on FRLN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: